Dr Ivan Coulter, founder and chief executive of Sigmoid, said the company had raised €25 million since it was founded in 2003. Photograph: Alan Betson

Sigmoid Pharma, a Dublin-based drug developer, has raised €5 million in new investment from Canadian company Pendopharm. The Irish firm, which is base(...)

Civitas is developing an inhaled form of the drug levadopa that is currently used by Parkinson’s patients in tablet form.

Irish private equity group Fountain Healthcare is one of the big winners following the sale of a company that has developed a experimental therapy fo(...)

Mathew Martoma, a former portfolio manager with SAC Capital Advisor Photographer: Peter Foley/Bloomberg

Mathew Martoma has been sentenced to nine years in prison for carrying out one of the biggest insider trading schemes on record in 2008 when he was w(...)

M&A activity in Ireland is at its strongest since 2008 with 42 deals announced during the first half of the year, according to new figures compile(...)

Steven Cohen: a judge ruled yesterday that the entire case against him and SAC can go forward. Photograph: Scott Eells/Bloomberg

A US federal judge has rejected billionaire investor Steven A Cohen’s bid to dismiss lawsuits by shareholders of pharma firms Elan and Wyeth who clai(...)

Blister packs of over-the-counter allergy medicines, manufactured by Perrigo. Perrigo agreed to buy Irish drug company Elan for $8.6 billion in 2013, thereby gaining a low-tax base for international expansion. Now it is being cited as a potential acquisition target for larger companies looking to pursue a similar strategy. Photograph: Andrew Harrer/Bloomberg

Dublin based drugmaker Perrigo may join Swiss based Actelion and UK-based medical device company Smith and Nephew as acquisition targets for US healt(...)

More than 70 US companies have shifted their tax domiciles to foreign addresses since 1983, mostly relocated their headquarters to Ireland, the UK, the Netherlands and Switzerland. Photograph: Reuters

The attraction of Ireland’s low-cost tax regime to American multinationals has again come under the spotlight in the US Congress after a new report fo(...)

Richard Pops, Alkermes chief executive, says that the company is not interested in being bought out as it nears the launch of new drugs.Photograph: Dara Mac Dónaill / THE IRISH TIMES

Dublin-based Alkermes has the low-tax domicile currently in vogue among multinational pharmaceutical companies but is not interested in being bought o(...)

Séamus Mulligan  co-founded Dublin-based Adapt with fellow serial pharmaceutical entrepreneurs David Brabazon and Eunan Maguire

Entrepreneur Séamus Mulligan has cashed in shares worth $86 million (€62 million) in Jazz Pharmaceuticals which will entirely be used to fund a new(...)

Forest Laboratories employs 320 people in Ireland. Dublin-headquartered Actavis, the world’s second-largest generic-drug maker by market value, is to buy Forest Labs for $25 billion. Photo: Jim Peppler

Actavis, the world’s second-largest generic-drug maker by market value, is to buy Forest Laboratories in a cash and stock deal valued at about(...)